Additionally, alterations in the ATX-LPA pathway have been implicated in metabolic and inflammatory disorders, such as obesity, insulin resistance, metabolic syndrome, cardiovascular disease, neurogenesis, and cancer [28, 29]. The gene discussed is LPA; the disease is obesity due to melanocortin 4 receptor deficiency.